Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5195 ARTÍCULOS , VIENDO DEL 1576 AL 1590

Advancing gene therapies, methods, and technologies for Parkinson's Disease and other neurological disorders

Fiandaca MS, Lonser RR, Elder JB, Ząbek M, Bankiewicz KS.

Neurol Neurochir Pol. 2020;54(3):220-231. doi: 10.5603/PJNNS.a2020.0046. Epub 2020 Jun 18.

Meta-Analysis of Gut Dysbiosis in Parkinson's Disease

Nishiwaki H, Ito M, Ishida T, Hamaguchi T, Maeda T, Kashihara K, Tsuboi Y, Ueyama J, Shimamura T, Mori H, Kurokawa K, Katsuno M, Hirayama M, Ohno K.

Mov Disord. 2020 Sep;35(9):1626-1635. doi: 10.1002/mds.28119. Epub 2020 Jun 18.

A Randomized, Controlled Trial of Exercise for Parkinsonian Individuals With Freezing of Gait

Silva-Batista C, de Lima-Pardini AC, Nucci MP, Coelho DB, Batista A, Piemonte MEP, Barbosa ER, Teixeira LA, Corcos DM, Amaro E Jr, Horak FB, Ugrinowitsch C.

Mov Disord. 2020 Sep;35(9):1607-1617. doi: 10.1002/mds.28128. Epub 2020 Jun 18.

Gastrointestinal surgical procedures affect levodopa pharmacokinetics in Parkinson's disease

Miyaue N, Yabe H, Nagai M, Nomoto M.

Parkinsonism Relat Disord. 2020 Jul;76:29-31. doi: 10.1016/j.parkreldis.2020.05.040. Epub 2020 Jun 5.

The Future of Targeted Gene-Based Treatment Strategies and Biomarkers in Parkinson's Disease

Polissidis A, Petropoulou-Vathi L, Nakos-Bimpos M, Rideout HJ.

Biomolecules. 2020 Jun 16;10(6):912. doi: 10.3390/biom10060912.

Ambient Air Pollution Increases the Risk of Cerebrovascular and Neuropsychiatric Disorders through Induction of Inflammation and Oxidative Stress

Hahad O, Lelieveld J, Birklein F, Lieb K, Daiber A, Münzel T.

Int J Mol Sci. 2020 Jun 17;21(12):4306. doi: 10.3390/ijms21124306.

Droxidopa as an effective treatment for refractory neurogenic orthostatic hypotension and reflex bradycardia in amyloid light-chain amyloidosis: a case report

Ho AH, Kinter CW, Wight J, Neelam AR, Krakow D.

J Med Case Rep. 2020 Jun 20;14(1):73. doi: 10.1186/s13256-020-02405-w.

Remodeling microglia to a protective phenotype in Parkinson's disease?

Awogbindin IO, Ishola IO, St-Pierre MK, Carrier M, Savage JC, Di Paolo T, Tremblay MÈ.

Neurosci Lett. 2020 Sep 14;735:135164. doi: 10.1016/j.neulet.2020.135164. Epub 2020 Jun 16.

Exercise and Sleep in Parkinson's Disease

Postuma RB.

Mov Disord. 2020 Jun;35(6):918-920. doi: 10.1002/mds.28032.

Safety and immunogenicity of the α-synuclein active immunotherapeutic PD01A in patients with Parkinson's disease: a randomised, single-blinded, phase 1 trial

Volc D, Poewe W, Kutzelnigg A, Lührs P, Thun-Hohenstein C, Schneeberger A, Galabova G, Majbour N, Vaikath N, El-Agnaf O, Winter D, Mihailovska E, Mairhofer A, Schwenke C, Staffler G, Medori R.

Lancet Neurol. 2020 Jul;19(7):591-600. doi: 10.1016/S1474-4422(20)30136-8.

Therapeutic potential of pharmacological agents targeting TRP channels in CNS disorders

Thapak P, Vaidya B, Joshi HC, Singh JN, Sharma SS.

Pharmacol Res. 2020 Sep;159:105026. doi: 10.1016/j.phrs.2020.105026. Epub 2020 Jun 17.

A novel rare variant of LRRK2 associated with familial Parkinson's disease: p.R1501W

Masuzugawa S, Nishioka K, Imai Y, Ogata J, Shojima Y, Li Y, Yoshino H, Hattori N.

Parkinsonism Relat Disord. 2020 Jul;76:46-48. doi: 10.1016/j.parkreldis.2020.05.035. Epub 2020 Jun 2.

Nocebo and lessebo effects

A Mestre T.

Int Rev Neurobiol. 2020;153:121-146. doi: 10.1016/bs.irn.2020.04.005. Epub 2020 Jun 9.

Placebo effects in pain

Colloca L.

Int Rev Neurobiol. 2020;153:167-185. doi: 10.1016/bs.irn.2020.04.001. Epub 2020 Jun 9.

Placebo responses in Parkinson's disease

Lou JS.

Int Rev Neurobiol. 2020;153:187-211. doi: 10.1016/bs.irn.2020.03.031. Epub 2020 Jun 9.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias